The application of metabolites derived from gut microbiota to the treatment of chronic kidney disease: a network pharmacology study
The gut microbiota metabolites exert beneficial effect on CKD by regulating multi-signaling pathway and multi-targets. This work provides a scientific support for the application of gut microbiota metabolites to CKD treatment.
Authors
- Kun Liu (ORCID: https://orcid.org/0000-0002-0115-7160)
- Pengyu Tao (ORCID: https://orcid.org/0000-0001-5024-8686)
- Weiguo Yao
- Jinlin Huo
Institutions
- Shantou University (CN)
- Jinshan Hospital of Fudan University (CN)
- First Affiliated Hospital of Shantou University Medical College (CN)
- Shanghai University of Medicine and Health Sciences (CN)
- CAO Group (United States) (US)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1097/js9.0000000000003895
- Citations
- 1
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.81